447 filings
Page 5 of 23
6-K
zna5 bro1mc4zwk8
18 Feb 21
Current report (foreign)
10:19am
6-K
31jbmrtvi675zukuk28
11 Feb 21
Current report (foreign)
4:44pm
FWP
0vpu vxjf9
8 Feb 21
Free writing prospectus
10:31am
424B3
gxvr xkpqio5m15
8 Feb 21
Prospectus supplement
8:56am
6-K
f6qs61g0ck1xjd
8 Feb 21
Current report (foreign)
8:44am
6-K
s94 yhkurlbi
8 Feb 21
Current report (foreign)
6:11am
6-K
uopy 4gx04
4 Feb 21
Current report (foreign)
3:23pm
6-K
b1v77 da9g7
2 Feb 21
Current report (foreign)
11:11am
6-K
ikl5ofg o51
8 Jan 21
Biofrontera announces preliminary revenue figures for the full year 2020
2:17pm
6-K
gfd6no1 b1h
7 Jan 21
Current report (foreign)
3:22pm
6-K
rsf1ik
6 Jan 21
Current report (foreign)
6:37am
S-8
9jcgjxtpojdf14401ut
28 Dec 20
Registration of securities for employees
6:06am
6-K
pyt3yg7hlw
22 Dec 20
Current report (foreign)
12:05pm
6-K
lyu57j1hlbz
7 Dec 20
Biofrontera enters into a license and supply agreement with Galenica AB for the marketing of Ameluz® in Scandinavia
10:01am
SC 13D/A
jzfrmgq7fksb7ru5lkp
27 Nov 20
Biofrontera / DEUTSCHE BALATON AKTIENGESELLSCHAFT ownership change
4:04pm
6-K
roymom0d4 fk20
27 Nov 20
Current report (foreign)
6:12am
6-K
yi4 anoobrrm
23 Nov 20
Managers’ transactions announcement according to article 19 MAR
3:57pm
6-K
vklnjkmxvz av2pqsk
23 Nov 20
Managers’ transactions announcement according to article 19 MAR
3:56pm
6-K
zkxftrqd4cz468o1fg2y
23 Nov 20
Managers’ transactions announcement according to article 19 MAR
3:53pm
6-K
nv5k2e
23 Nov 20
Current report (foreign)
7:17am